CACHEXIA
Clinical trials for CACHEXIA explained in plain language.
Never miss a new study
Get alerted when new CACHEXIA trials appear
Sign up with your email to follow new studies for CACHEXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer patients battling appetite loss
Symptom relief Not yet recruitingThis study tests a drug called nanocrystalline megestrol acetate to see if it can help prevent weight loss and improve appetite in people with advanced liver cancer who are already receiving standard treatments. About 88 participants will be randomly assigned to receive either th…
Matched conditions: CACHEXIA
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated May 17, 2026 11:31 UTC
-
New hope for cancer patients suffering from wasting syndrome
Symptom relief Not yet recruitingThis study tests a new drug called DS010 in 58 adults with cancer who are experiencing cachexia—a condition causing severe weight and muscle loss. The goal is to see if DS010 is safe and can help patients gain weight and improve muscle mass. The trial has two phases: first checki…
Matched conditions: CACHEXIA
Phase: PHASE1, PHASE2 • Sponsor: Dartsbio Pharmaceuticals Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Could a new drug combo help liver cancer patients regain appetite and weight?
Symptom relief Not yet recruitingThis study looks at whether adding nanocrystalline megestrol acetate to standard treatment can improve appetite and body mass index (BMI) in people with advanced liver cancer who are experiencing cachexia (severe weight loss and muscle wasting). About 68 participants will be rand…
Matched conditions: CACHEXIA
Phase: PHASE3 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC